Marfan Syndrome: Clinical Trials

3 trials for Marfan Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Completed 1

Follow Marfan Syndrome: new trials by email Literature Review of Marfan Syndrome trials Research Report on Marfan Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Oxford Marfan Trial
Irbesartan 150-300mg capsules daily for 6 months, Doxycycline 100-200mg capsules daily for 6 months, Doxycycline placebo capsules daily for 6 months - Marfan Syndrome
Phase 2UnknownUniversity of Oxford562013-10-012015-06-09
Losartan Versus Atenolol for the Treatment of Marfan Syndrome
Losartan, Atenolol - Marfan Syndrome
Phase 2CompletedUniversity of British Columbia172008-01-012012-07-12
A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Losartan and Atenolol or Propranolol, Atenolol or Propranolol - Marfan Syndrome
Phase 2UnknownNational Taiwan University Hospital442007-02-012010-06-09

Broader conditions

Abnormalities, Multiple (3)  ·  Bone Diseases (3)  ·  Bone Diseases, Developmental (3)  ·  Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Connective Tissue Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Heart Defects, Congenital (3)  ·  Heart Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Skin and Connective Tissue Diseases (3)

Interventions

Atenolol (2)  ·  Losartan (2)  ·  Doxycycline (1)  ·  Irbesartan (1)  ·  Propranolol (1)

Sponsors

National Taiwan University Hospital (1)  ·  University of British Columbia (1)  ·  University of Oxford (1)

Countries

Canada (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Cornelius van Breemen, MD (1)  ·  George Sandor, MD, FRCPC (1)  ·  J Colin Forfar, BSc (hons), MA(Oxon), MD, PhD, (1)  ·  James E. Potts, MD (1)  ·  Mei-Hwan Wu (1)

Results publications

PMID 23321647, PMID 25465809